BioWorld, one of the leading news services delivering actionable intelligence on the most innovative human therapies in development has been recognized by the Specialized Information Publishing Association (SIPA), a global organization that serves providers of news and information across multiple industries, with five awards as part of their 2018 competition. The awards are judged by peers in specialty publishing.
Prior to 2018, BioWorld has won 48 SIPA awards dating back to 1998. Of those, the publication has placed in the Best Daily Publication category nine times.
This year, BioWorld was nominated in five different categories and walked away with significant honors from the awards ceremony held on Wednesday, June 6th, 2018. Following are the results:
- Best Spot News or Single News Article: first place
Flaws in the IPR process: How Allergan tried to protect its billion-dollar product from generic competition, by Mari Serebrov, regulatory editor
- BioWorld – Best Daily Publication, second place & BioWorld MedTech – Best Daily Publication, third place
- Best Scientific Writing or Technical Reporting: second place
Researchers leapfrog forward with 20x improvement in neuron-level brain monitoring, by Stacy Lawrence, staff writer
- Best Scientific Writing or Technical Reporting: honorable mention
IL drink to that: 33 skidoo as Anaptysbio exiting I.V. for subcu in eczema bid, by Randy Osborne, staff writer
As the media industry endures a tumultuous transition due to the rise of social media, self-proclaimed news outlets and “free” content, targeting news for specific markets or industries, has become more important than ever”
– Lynn Yoffee, News Director at BioWorld
BioWorld has stood the test of time in the ever-changing media environment as we continue to grow and excel due to our commitment to the core principles of ethical journalism and producing insightful news based on direct interviews bolstered with invaluable data from BioWorld research, Cortellis, IPD, and other Clarivate Analytics resources”
– Lynn Yoffee, News Director at BioWorld
BioWorld delivers actionable intelligence on the most innovative human therapies in development. With writers and editors stationed around the globe, BioWorld reports the breaking news — and provides key perspective — on hundreds of therapies and technologies in development, the companies behind those candidates, the business development transactions that evolve the market, and the regulatory hurdles that both challenge and guard the process.
